In Silico Clinical Trials

Generally accepted principles suggest that patient involvement should extend well beyond consideration as research subjects. Patients are key stakeholders in all aspects of trial design & execution. Patient-centric drug development also offers a huge opportunity to define meaningful outcomes from the patient perspective, as a way to ensure the needs and priorities of patient populations are reflected in research. Although efforts are made to control risks to clinical trial participants, some risk may be unavoidable because of the uncertainty inherent in clinical research involving new medical products. It's important, therefore, that people make their decision to participate in a clinical trial only after they have a full understanding of the entire process and the risks that may be involved.

 

  • Innovative approaches to patient recruitment
  • Innovative partnering in clinical research
  • Strategic development towards FDA approval
  • Innovation in clinical technologies
  • Mobile technologies in clinical research
  • Collaborate with patients to boost trial productivity
  • Implementation of mobile health technologies
  • Global needs for mobile health and potential technologies
  • Embracing the clinical trial of the future
  • Designing the clinical trial of the future
  • The good, the bad and the ugly of clinical trials
  • Cloud based medical image management for clinical trials
  • Clinical trial site of the future
  • Paperless clinical trials

Related Conference of In Silico Clinical Trials

In Silico Clinical Trials Conference Speakers